GRI Bio Inc
NASDAQ:GRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
GRI Bio Inc (GRI) under the Base Case is 4.57 USD per share.
Compared with the current market price of 1.83 USD, the stock appears
Undervalued by 60% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What GRI Bio Does
GRI Bio Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in La Jolla, California and currently employs 2 full-time employees. The company went IPO on 2021-02-10. GRI Bio, Inc. is a clinical-stage biotechnology company. The firm is focused on advancing a pipeline of Natural Killer T (NKT) modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseases.
- Headquarters
- United States of America US
- Employees
- 2
- IPO date
- Feb 10, 2021
Earnings Waterfall
GRI Bio Inc
What is the Intrinsic Value of one GRI stock?
The intrinsic value for GRI Bio Inc (GRI) under the Base Case is 4.57 USD.
Is GRI stock undervalued or overvalued?
Compared with the current market price of 1.83 USD, the stock appears Undervalued by 60% .
